Alliance Submits Comments to the DEA Proposed Rule on Prescribing Controlled Substance via Telemedicine

The Alliance for Connected Care submitted comments in response to the request for information from the Drug Enforcement Administration’s (DEA) proposed rule, Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation.

The Alliance highlights its concerns that the rule does not satisfy multiple congressional directives to establish a process for providers to prescribe controlled substances via telemedicine without a prior, in-person medical evaluation. The Alliance urges the DEA to move forward with the development of a special telemedicine registration to ensure access to medically necessary services are available via telemedicine.

Additionally, the Alliance provided specific feedback on proposals in the proposed rule. Broadly, the Alliance was disappointed by the approach taken by the DEA in the proposed rule.

To read the full letter, see below or click here.